× Current Issue Archive Submit Article
Conflicts of Interest Copyright and Access Open access policy Editorial Policies Peer Review Policy Privacy Statement Publishing Ethics
Editor in chief Associate Editors Advisory Board International Editors
Contact Us About Us Aim & Scope Abstracting And Indexing Author Guidelines Join As Editor

Evaluating the level of IFN Gamma in diabetic patients



Abstract

Introduction: Diabetes is one of the most common diseases in the world. Its prevalence is estimated to be 5% in Iran and it is increasing by rate of 1% per year. It is diagnosable by FBS and HbA1C tests. Objective: The objective of this study was to evaluate the relationship between HbA1C fluctuations and level of interferon gamma and Hs CRP in diabetic patients. Methodology: the research was conducted in the form of case and control, in which case group included 45 diabetic patients whose HbA1C levels were more than 6 AU / ML and 45 healthy subjects were selected as control group. Blood samples were taken from all subjects and HbA1C and interferon-gamma tests were performed using the ELISA method according to the kit's guidelines. Results: Mean HbA1C was 8.8 AU/ML and 5.5 AU/ML in case group and control group, respectively.  IFN Gamma level in subjects of case group was about 84.7% more than normal level.  Conclusion: According to the obtained data, the mean serum level of IFN-γ was more in diabetic patients with HbA1C than that in the normal people, and this difference was statistically significant.




Contact Meral


Meral Publications
www.meralpublisher.com

Davutpasa / Zeytinburnu 34087
Istanbul
Turkey

Email: [email protected]
Tell: +905344998991